$6.89
0.274.08%
À la fermeture: -
$6.94
0.050.73%
Après les heures de négociation: Nov 7, 7:04 PM EDT
Comments
Loading...
Rapport sur les intérêts à découvert
L'intérêt à découvert sur Immuneering Corp (NASDAQ:IMRX) a augmenté lors de la dernière période de déclaration, augmentant de en hausse de 6.28M à 7.69M. Cela représente 14.05% des actions disponibles au public de l'entreprise.
Sur la base du volume moyen récent de 2.20M actions échangées par jour, il faudrait 3.5 jour(s) aux détenteurs de cet intérêt à découvert pour clôturer leurs positions sans faire monter brusquement le cours de l'action.
Intérêt à court terme
7.69M
Intérêt à court terme %
14.1%
Jours de couverture
3.5
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
IMRX | Immuneering Corporation Class | 10/15/2025 | 10/24/2025 | 14.05% | 54,732,757 | 7,692,365 | 2,199,961 | 3.5 | |
IMRX | Immuneering Corporation Class | 09/30/2025 | 10/09/2025 | 11.47% | 54,732,757 | 6,278,620 | 4,478,367 | 1.4 | |
IMRX | Immuneering Corporation Class | 09/15/2025 | 09/24/2025 | 8.95% | 33,064,284 | 2,958,155 | 1,101,149 | 2.69 | |
IMRX | Immuneering Corporation Class | 08/29/2025 | 09/10/2025 | 5.54% | 33,064,284 | 1,830,280 | 1,379,633 | 1.33 | |
IMRX | Immuneering Corporation Class | 08/15/2025 | 08/26/2025 | 5.69% | 27,812,935 | 1,581,442 | 345,613 | 4.58 | |
IMRX | Immuneering Corporation Class | 07/31/2025 | 08/11/2025 | 5.66% | 27,479,760 | 1,555,893 | 453,303 | 3.43 | |
IMRX | Immuneering Corporation Class | 07/15/2025 | 07/24/2025 | 6.02% | 27,479,760 | 1,654,759 | 1,052,197 | 1.57 | |
IMRX | Immuneering Corporation Class | 06/30/2025 | 07/10/2025 | 6.28% | 27,479,760 | 1,724,555 | 5,313,544 | 1 | |
IMRX | Immuneering Corporation Class | 06/13/2025 | 06/25/2025 | 3.25% | 27,479,760 | 893,835 | 344,682 | 2.59 | |
IMRX | Immuneering Corporation Class | 05/30/2025 | 06/10/2025 | 3.36% | 27,479,760 | 924,552 | 253,723 | 3.64 | |
IMRX | Immuneering Corporation Class | 05/15/2025 | 05/27/2025 | 2.40% | 27,479,760 | 660,772 | 232,873 | 2.84 | |
IMRX | Immuneering Corporation Class | 04/30/2025 | 05/09/2025 | 3.15% | 27,479,760 | 866,083 | 141,400 | 6.13 | |
IMRX | Immuneering Corporation Class | 04/15/2025 | 04/25/2025 | 2.81% | 27,479,760 | 771,281 | 161,481 | 4.78 | |
IMRX | Immuneering Corporation Class | 03/31/2025 | 04/09/2025 | 3.77% | 28,303,175 | 1,067,482 | 178,607 | 5.98 | |
IMRX | Immuneering Corporation Class | 03/14/2025 | 03/25/2025 | 5.02% | 28,303,175 | 1,421,410 | 203,201 | 7 | |
IMRX | Immuneering Corporation Class | 02/28/2025 | 03/11/2025 | 6.94% | 23,466,371 | 1,627,849 | 221,294 | 7.36 | |
IMRX | Immuneering Corporation Class | 02/14/2025 | 02/26/2025 | 7.40% | 23,466,371 | 1,735,510 | 331,277 | 5.24 | |
IMRX | Immuneering Corporation Class | 01/31/2025 | 02/11/2025 | 9.21% | 23,466,371 | 2,160,941 | 433,418 | 4.99 | |
IMRX | Immuneering Corporation Class | 01/15/2025 | 01/27/2025 | 12.90% | 23,466,371 | 3,027,573 | 10,199,290 | 1 | |
IMRX | Immuneering Corporation Class | 12/31/2024 | 01/10/2025 | 7.48% | 23,466,371 | 1,755,894 | 488,982 | 3.59 | |
IMRX | Immuneering Corporation Class | 12/13/2024 | 12/24/2024 | 9.77% | 23,466,371 | 2,291,983 | 1,240,208 | 1.85 | |
IMRX | Immuneering Corporation Class | 11/29/2024 | 12/10/2024 | 6.90% | 23,466,371 | 1,618,097 | 293,860 | 5.51 | |
IMRX | Immuneering Corporation Class | 11/15/2024 | 11/26/2024 | 8.67% | 23,466,371 | 2,035,375 | 350,617 | 5.81 | |
IMRX | Immuneering Corporation Class | 10/31/2024 | 11/11/2024 | 9.27% | 22,069,278 | 2,045,626 | 554,686 | 3.69 | |
IMRX | Immuneering Corporation Class | 10/15/2024 | 10/24/2024 | 6.88% | 22,069,278 | 1,519,217 | 3,015,721 | 1 | |
IMRX | Immuneering Corporation Class | 09/30/2024 | 10/09/2024 | 7.40% | 22,069,278 | 1,633,767 | 13,825,630 | 1 | |
IMRX | Immuneering Corporation Class | 09/13/2024 | 09/24/2024 | 13.69% | 22,069,278 | 3,022,085 | 17,067,843 | 1 | |
IMRX | Immuneering Corporation Class | 08/30/2024 | 09/11/2024 | 6.89% | 22,069,278 | 1,520,294 | 384,861 | 3.95 | |
IMRX | Immuneering Corporation Class | 08/15/2024 | 08/26/2024 | 8.99% | 22,069,278 | 1,983,486 | 7,014,175 | 1 | |
IMRX | Immuneering Corporation Class | 07/31/2024 | 08/09/2024 | 12.20% | 22,069,278 | 2,693,469 | 663,108 | 4.06 | |
IMRX | Immuneering Corporation Class | 07/15/2024 | 07/24/2024 | 13.03% | 22,069,278 | 2,875,891 | 223,546 | 12.86 | |
IMRX | Immuneering Corporation Class | 06/28/2024 | 07/10/2024 | 15.76% | 22,069,278 | 3,477,135 | 453,162 | 7.67 | |
IMRX | Immuneering Corporation Class | 06/14/2024 | 06/26/2024 | 16.71% | 22,069,278 | 3,687,343 | 264,988 | 13.92 | |
IMRX | Immuneering Corporation Class | 05/31/2024 | 06/11/2024 | 15.72% | 22,069,278 | 3,469,829 | 172,380 | 20.13 | |
IMRX | Immuneering Corporation Class | 05/15/2024 | 05/24/2024 | 15.98% | 22,069,278 | 3,527,138 | 295,006 | 11.96 | |
IMRX | Immuneering Corporation Class | 04/30/2024 | 05/09/2024 | 14.54% | 22,069,278 | 3,209,213 | 420,664 | 7.63 | |
IMRX | Immuneering Corporation Class | 04/15/2024 | 04/24/2024 | 12.37% | 22,069,278 | 2,730,363 | 692,256 | 3.94 | |
IMRX | Immuneering Corporation Class | 03/28/2024 | 04/09/2024 | 18.34% | 15,678,470 | 2,875,898 | 2,346,133 | 1.23 | |
IMRX | Immuneering Corporation Class | 03/15/2024 | 03/26/2024 | 16.65% | 15,678,470 | 2,610,384 | 995,597 | 2.62 | |
IMRX | Immuneering Corporation Class | 02/29/2024 | 03/11/2024 | 17.12% | 15,678,470 | 2,684,594 | 41,063 | 65.38 | |
IMRX | Immuneering Corporation Class | 02/15/2024 | 02/27/2024 | 17.26% | 15,664,319 | 2,702,910 | 50,512 | 53.51 | |
IMRX | Immuneering Corporation Class | 01/31/2024 | 02/09/2024 | 17.06% | 15,664,319 | 2,672,704 | 46,652 | 57.29 | |
IMRX | Immuneering Corporation Class | 01/12/2024 | 01/24/2024 | 16.82% | 15,664,319 | 2,635,284 | 42,767 | 61.62 | |
IMRX | Immuneering Corporation Class | 12/29/2023 | 01/10/2024 | 16.80% | 15,664,319 | 2,631,768 | 66,742 | 39.43 | |
IMRX | Immuneering Corporation Class | 12/15/2023 | 12/27/2023 | 16.23% | 15,664,319 | 2,542,407 | 86,673 | 29.33 | |
IMRX | Immuneering Corporation Class | 11/30/2023 | 12/11/2023 | 16.39% | 15,664,319 | 2,568,003 | 64,606 | 39.75 | |
IMRX | Immuneering Corporation Class | 11/15/2023 | 11/27/2023 | 17.62% | 15,664,319 | 2,760,024 | 79,421 | 34.75 |
À la recherche des actions les plus vendues à découvert?